Notably, 6-diazo-5-oxo-L-norleucine (DON), a glutamine antagonist with a structure similar to glutamine, efficiently reverses cognitive decline in rodent HAND models by inhibiting glutamate synthesis through interacting with glutaminase in microglia [110]. The gene discussed is GLS; the disease is HIV-associated neurocognitive disorder.